See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
09:07am, Tuesday, May 13, 2025
Monopar Therapeutics Reports Increased Q1 Losses Amid Rising Operating Expenses and R&D Costs
Monopar Therapeutics Inc. (NASDAQ: MNPR) has recently released its financial results for the first quarter ended March 31, 2025. Below is an overview of the company's financial performance and key points from the income statement. Financial Highlights Net Loss: The company's net loss was $2.625 ...
Read More